Caspofungin versus Liposomal Amphotericin B for Empirical Antifungal Therapy in Patients with Persistent Fever and NeutropeniaThomas J. Walsh, Ben E. dePauw, Oliver A. Cornely et al.|New England Journal of Medicine|2004Cited by 922
Pharmacokinetics, Safety, and 48-Week Efficacy of Oral Raltegravir in HIV-1-Infected Children Aged 2 Through 18 YearsSharon Nachman, H. N. Ndiweni, Naiyu Zheng et al.|Clinical Infectious Diseases|2013Cited by 60
Safety and efficacy of doravirine as first-line therapy in adults with HIV-1: week 192 results from the open-label extensions of the DRIVE-FORWARD and DRIVE-AHEAD phase 3 trialsChloe Orkin, Christine Katlama, Jean‐Michel Molina et al.|The Lancet HIV|2023Cited by 31